Skip to content

Improving Medication Adherence Through a Transitional Care Pharmacy Practice Model

Improving Medication Adherence Through a Transitional Care Pharmacy Practice Model

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02047448
Enrollment
180
Registered
2014-01-28
Start date
2014-01-31
Completion date
2017-04-28
Last updated
2017-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Pulmonary Disease, Chronic Obstructive

Keywords

transition of care, care transitions, readmission, medication, adherence, medication management, medication reconciliation, patient counseling, pharmacist

Brief summary

The purpose of this pilot study is to determine if medication adherence is improved by a transitional care pharmacy practice model designed to integrate hospital and community pharmacists in the care and education of patients with heart failure or COPD who are discharged from a community hospital to home. The hospital and community pharmacists will collaborate with each other, the patient, and other practitioners including the primary care physician, nurse, and case manager to prevent and correct medication-related problems and attempt to improve patient outcomes especially during the error-prone transition from hospital to home.

Interventions

The hospital pharmacist will meet with the patient and complete medication reconciliation, assess the patient's understanding of the medications, and identify medication-related problems. The hospital pharmacist will complete a pharmacist discharge care plan and a copy will be sent to the participating community pharmacist. The patients will be scheduled for the first meeting with their community pharmacist within 1 week of hospital discharge. The community pharmacist will interview the patient about their general health and any current symptoms of heart failure or COPD, identify any additional medication-related problems, follow-up on any issues as described in the pharmacist discharge care plan, and provide patient education. The patients will then meet with their community pharmacist for counseling and patient education at monthly intervals for 6 months following hospital discharge.

Sponsors

Moses Taylor Hospital Foundation
CollaboratorUNKNOWN
Commonwealth Health
CollaboratorUNKNOWN
Community Pharmacy Foundation
CollaboratorOTHER
Wilkes University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* admitted to hospital with a primary or secondary diagnosis of heart failure or COPD * anticipated eventual discharge to home * agreeable to participate in monthly counseling sessions (if randomized to intervention group) from a participating community pharmacist

Exclusion criteria

* presence of cognitive impairment or dementia that would significantly prevent effective patient education and counseling * non English-speaking * anticipated discharge to a long-term care or skilled nursing facility on a permanent basis * permanent long-term care facility residents * surgical patients * hospice patients * patients who die within 30 days of initial study hospitalization

Design outcomes

Primary

MeasureTime frameDescription
Medication Adherence6 monthsThe primary endpoint will be medication adherence as measured by the Proportion of Days Covered (PDC) calculation. This is calculated by dividing the total days' supply dispensed by 180 days. Medications considered in this calculation will include those used for the treatment of heart failure or COPD and known to improve outcomes. The composite PDC will be an average of the individual PDC for each drug class.

Secondary

MeasureTime frameDescription
Medication related problems6 monthsActual or potential medication-related problems (MRP) that are identified by the hospital and participating community pharmacists will be categorized based on an MRP classification tool.
Patient Satisfaction6 monthsThe Care Transitions Measure (CTM-3) is a validated survey to assess the patient's satisfaction with the quality of transitional care during hospitalization and will be completed by the patient following hospital discharge. The patient's satisfaction with the services provided by the community pharmacies will be assessed with the Consumer Experience with Pharmacy Services survey (© Pharmacy Quality Alliance).
Hospital readmissions or ED visits6 monthsHospital readmissions are defined as an unplanned and overnight admission to the hospital

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026